The Patent Finder

Vaccinex, Inc.

Also on record
Records under this name other than the patents Vaccinex, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 41 patents it holds.

Back to Vaccinex, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,371,352Modified Glycolipids and Methods of Making and Using the Same
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,201,719Combination Therapy with SEMAPHORIN-4D Blockade (SEMA4D) and DC1 Therapy
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,660,330Combination Therapy with SEMAPHORIN-4D Blockade (SEMA4D) and DC1 Therapy
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,597,765Use of SEMAPHORIN-4D Binding Molecules for the Treatment of Rett Syndrome
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,111,950Modified Glycolipids and Methods of Making and Using the Same
Formerly held
Lapsed on the fee record
Ended Oct 30, 2026 · Low confidence
Lapsed on the fee recordEnded Oct 30, 2026Low confidence
US 8,637,026ANTI-C35 Antibody Combination Therapies and Methods
Lapsed on the fee record
Ended Jan 28, 2026 · High confidence
Lapsed on the fee recordEnded Jan 28, 2026High confidence
US 9,809,654Targeted cd1d molecules
Lapsed on the fee record
Ended Nov 7, 2025 · High confidence
Lapsed on the fee recordEnded Nov 7, 2025High confidence
US 7,858,559In Vitro Methods of Producing and Identifying Immunoglobulin Molecules in Eukaryotic Cells
Formerly held
Term ended
Term ended Mar 30, 2025 · High confidence
Term endedTerm ended Mar 30, 2025High confidence
US 9,603,922Modulation of NKT Cell Activity with Antigen-Loaded CD1d Molecules
Lapsed on the fee record
Ended Mar 28, 2025 · High confidence
Lapsed on the fee recordEnded Mar 28, 2025High confidence
US 8,741,810In Vitro Methods of Producing and Identifying Immunoglobulin Molecules in Eukaryotic Cells
Formerly held
Term ended
Term ended Jan 17, 2025 · High confidence
Term endedTerm ended Jan 17, 2025High confidence
10 of 22 patents shown.
Pro members see all 22.
Pro members: see all 22 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited